Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection (redOrbit)
DETROIT, May 28 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) recorded net sales of $337.2 million during Fiscal 2009 compared to $350.4 million during Fiscal 2008.

FDA Approves New Total Ankle Replacement System (Medical News Today)
The U.S. Food and Drug Administration approved a total ankle replacement system for arthritic or deformed ankles that may preserve some range of motion in the joint. The new prosthesis is a mobile-bearing device, which relies on bearings that move across a surface of polyethylene, a flexible plastic. The device is the first of its type.

Warner Chilcott Announces FDA Acceptance Of NDA Submission For Low Dose Oral Contraceptive (PharmaceuticalOnline)
Warner Chilcott Limited (Nasdaq: WCRX ) announced today that the U.S. Food and Drug Administration (FDA) has filed for standard review the new drug application (NDA) for WC 3016, a low dose oral contraceptive. The NDA for WC 3016 was submitted by its subsidiary, Warner Chilcott Company, LLC, on March 26, 2009.